Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards

We’re delighted to announce that we’ve won the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Product Considerations in Sterile Drug Formulation Development

Discover the critical product decisions in sterile drug formulation development. Learn how planning with your CDMO can streamline your path.
Why Project Management Is the Real Differentiator for CDMOs

Discover why project management is the critical success factor for CDMO collaborations. Explore Upperton’s approach.
Nikki Whitfield, CEO of Upperton Pharma Solutions, Honoured with ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025.

Nikki Whitfield, CEO of Upperton, has received the ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025
Finished Dosage Forms vs. APIs: What’s the Difference in Pharmaceutical Manufacturing?

Explore the key differences between Finished Dosage Forms (FDFs) and APIs in drug development and manufacturing.
Upperton Named in The Sunday Times Best Places To Work 2025 Accreditation

We’re delighted to share that Upperton has officially been accredited as on of the Sunday Time Best Places to Work 2025
Upperton Pharma Solutions Named One of The Sunday Times Best Places to Work 2025

We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2025
Step inside Upperton’s R&D Laboratories

Our Approach Project Initiation and Onboarding We typically initiate projects within two to three weeks of proposal acceptance. During this time, we manage project onboarding and procure any necessary materials. Our analytical team plays a crucial role in onboarding new methods, confirming their suitability, and ensuring readiness for the subsequent stages of your project. This […]
Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.

Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
Management Spotlight with Laura Mason

Discover more about our team. In this Spotlight, meet our Director of Pharmaceutical Sciences, Laura Mason, on her journey with Upperton.